The Swiss drugmaker Roche has said it will put $50bn (£37bn) into manufacturing in the US over the next five years, joining the queue of companies unveiling investments to try to head off potentially punitive Donald Trump tariffs.
Roche said on Tuesday the investment would create more than 12,000 jobs, including 6,500 in construction and 1,000 at new and expanded existing facilities in the US, including factories and distribution centres in Kentucky, New Jersey and California.
